close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Choose your License

loading animation for AJAX calls

Global Markets for Orphan Drugs

REPORT HIGHLIGHTS

The global market for orphan drugs reached nearly $86.1 billion in 2012. The market is expected to reach $112.1 billion in 2017 for a compound annual growth rate (CAGR) of 5.4%.

This report provides:

  • An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, and future growth trends
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Detailed discussion of successful orphan products
  • Detailed analysis of blockbuster orphan drugs
  • The rising influence of pharmacogenomics in the orphan drug market
  • A discussion of specific rare diseases for which orphan drugs exist
  • Analysis of the most promising therapeutic areas in the industry and leading orphan drugs in these areas
  • An outline of legislation and regulation, including public and private agencies involved in support and development
  • Technology trends analysis within the orphan drug market
  • Comprehensive company profiles of major players in the industry.

SAMPLE FIGURE
GLOBAL SALES OF ORPHAN DRUGS BY TYPE, 2010-2017
($ MILLIONS)
GLOBAL SALES OF ORPHAN DRUGS BY TYPE, 2010-2017
To Contact us, click here  help


Source: BCC Research

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVES

The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry.  BCC’s goal in conducting this study is to provide an overview of the current and future global market for orphan drugs.  The key objective is to present a comprehensive analysis of current orphan drugs and those under development as important therapies and treatments for rare diseases.

This report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market.  The market for each drug listed by its generic name/active ingredient and approved indication(s) is also analyzed in this report.

A detailed analysis of the structure of the orphan drug industry has been conducted.  Revenues are broken down by region drug type (i.e., biological and nonbiological), active ingredient and area of medical application.  Sales figures are estimated for the five-year period from 2012 through 2017.

Applications for orphan drugs are also discussed in the report, with an emphasis on the usage of the drugs in various disease segments.  The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

Extensive research in the field of orphan drugs has resulted in therapeutic treatments for a number of rare diseases.  Most of the big pharmaceutical companies have now begun to explore the advantages of orphan drugs as a major source of profit and a steady market.

R&D spending, competition and new technologies are increasing.  Advances, new product launches and assistance from regulatory bodies are positively impacting the growth of the market for orphan drugs in the near term.  This study examines these factors.

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE

This study focuses on the manufacturers and users of orphan drugs and its market growth.  Pharmaceutical biotechnical companies, research institutes and physicians will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study includes orphan drugs in pharmaceutical markets worldwide.  BCC analyzes each market and its applications, regulatory environment, technology, market projections and market shares.  Technological issues include the latest trends and developments.  The emerging market for orphan drugs includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study.  BCC conducted a comprehensive literature search, which included technical newsletters and journals and many other sources.  Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study.  Included were manufacturers and end users of orphan drugs within the therapeutic categories examined and various disease sector industries.  Data were gathered from various industry sources.  BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts.  Exhaustive investigations of databases by key terminology were completed.  In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study.  The project manager is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.  Some of the other reports she has prepared for BCC include Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

BCC ONLINE SERVICES

BCC Research offers an online information retrieval service.  Its home page, located at www.bccresearch.com, enables readers to:

  • Examine BCC’s complete catalog of Market Research Reports and place direct orders.
  • Subscribe to any of BCC’s many industry newsletters.
  • Read announcements of upcoming reports and newly launched newsletters.
  • Register for BCC’s well-known conferences.
  • Request additional information about any BCC product.
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature.  This information does not constitute managerial, legal or accounting advice; nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature.  The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

REPORT TOC

Pricing on the website is provided for single users and 2-5 users licenses only. Please contact us at (+1)781-489-7301 or send an email to help@bccresearch.com to purchase multi-user licenses.
  Title/Chapter Name Pages Price
Global Markets for Orphan Drugs 182 $6650
Chapter- 1: INTRODUCTION - Complimentary 3 $0
  Show Details
Chapter- 2: EXECUTIVE SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 23 $1261
  Show Details
Chapter- 4: NEW PRODUCT DEVELOPMENT AND REGULATION OF ORPHAN DRUGS 21 $1151
  Show Details
Chapter- 5: GLOBAL MARKET FOR ORPHAN DRUGS 32 $1754
  Show Details
Chapter- 6: MARKET ANALYSIS OF BIOLOGICAL ORPHAN DRUGS 34 $1863
  Show Details
Chapter- 7: MARKET ANALYSIS OF NONBIOLOGICAL ORPHAN DRUGS 34 $1863
  Show Details
Chapter- 8: PATENT ANALYSIS 7 $384
  Show Details
Chapter- 9: CURRENT SITUATION 4 $219
  Show Details
Chapter- 10: COMPANY PROFILES 21 $1151
  Show Details
 
  List of Tables
  List of Figures
 
  • Purchase Report
  • Download Table of Contents
  • Contact Us